SHIELD THERAPEUTICS PLC ORD 1.5吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
22 0 公告 FDA approves extension for ACCRUFeR? SHIELD THERAPEUT资讯 12-22 15:22
24 0 公告 Block Listing Application SHIELD THERAPEUT资讯 12-18 16:02
20 0 公告 Shield Wins Gold at Titan Branding Awards SHIELD THERAPEUT资讯 12-11 15:26
33 0 公告 Amends Senior Secured Debt Financing SHIELD THERAPEUT资讯 12-03 15:49
23 0 公告 Initiation of a Phase II Clinical Trial in Japan SHIELD THERAPEUT资讯 11-14 15:47
25 0 公告 ACCRUFeR Pediatric PK Results to be Presented SHIELD THERAPEUT资讯 11-11 15:20
17 0 公告 ACCRUFeR receives Authorisation by Korean Ministry SHIELD THERAPEUT资讯 11-07 16:10
25 0 公告 Q3 2025 Trading Update SHIELD THERAPEUT资讯 10-23 14:16
33 0 公告 Grant of Share Options to Chief Executive Officer SHIELD THERAPEUT资讯 10-14 22:09
23 0 公告 Total Voting Rights SHIELD THERAPEUT资讯 10-02 01:29
25 0 公告 Positive efficacy and tolerance in pediatric trial SHIELD THERAPEUT资讯 10-02 01:29
17 0 公告 £1.5 million placing supporting growth of ACCRUFe SHIELD THERAPEUT资讯 09-15 14:21
33 0 公告 ACCRUFeR? assigned Priority Review in US by FDA SHIELD THERAPEUT资讯 09-04 14:28
27 0 公告 Interim results for the six months ended 30 Jun 25 SHIELD THERAPEUT资讯 09-03 21:22
25 0 公告 Data published -European Journal of Heart Failure SHIELD THERAPEUT资讯 08-27 14:54
39 0 公告 Interim results for the six months ended 30 Jun 25 SHIELD THERAPEUT资讯 08-21 19:10
35 0 公告 Q2 2025 Trading Update SHIELD THERAPEUT资讯 07-23 14:26
51 0 公告 Result of AGM SHIELD THERAPEUT资讯 05-23 00:24
43 0 公告 Audited results for the year ended 31 Dec 2024 SHIELD THERAPEUT资讯 04-24 14:38
37 0 公告 Licence Agreement in Japan for ACCRUFeR? SHIELD THERAPEUT资讯 04-22 15:40
39 0 公告 Q1 2025 Trading Update SHIELD THERAPEUT资讯 04-17 18:24
49 0 公告 ACCRUFeR? launched in Canada SHIELD THERAPEUT资讯 03-11 15:25
50 0 公告 PDMR Transaction Notification SHIELD THERAPEUT资讯 02-14 00:26
55 0 公告 Grant of Share Options SHIELD THERAPEUT资讯 02-13 15:17
58 0 公告 Unaudited full year trading update SHIELD THERAPEUT资讯 02-05 15:18
56 0 公告 Anders Lundstrom appointed CEO SHIELD THERAPEUT资讯 01-27 15:19
70 0 公告 Result of General Meeting & Total Voting Rights SHIELD THERAPEUT资讯 12-24 19:28
78 0 公告 Results of RetailBook Offer SHIELD THERAPEUT资讯 12-23 15:17
78 0 公告 Subscription by AOP Health to raise US$10 million SHIELD THERAPEUT资讯 12-06 19:33
91 0 公告 RetailBook Offer SHIELD THERAPEUT资讯 12-06 19:33
80 0 公告 Business Update SHIELD THERAPEUT资讯 11-21 15:17
73 0 公告 Q3 Trading Update SHIELD THERAPEUT资讯 10-29 15:08
67 0 公告 Results from Phase 3 paediatric study SHIELD THERAPEUT资讯 09-25 14:12
58 0 公告 Interim results SHIELD THERAPEUT资讯 09-04 14:47
77 0 公告 ACCRUFeR Approved by Health Canada SHIELD THERAPEUT资讯 08-27 15:19
61 0 公告 Notice of interim results SHIELD THERAPEUT资讯 08-14 15:10
68 0 公告 Unaudited Q2 2024 Trading Update SHIELD THERAPEUT资讯 07-24 15:18
68 0 公告 Directorate Change SHIELD THERAPEUT资讯 07-24 15:08
70 0 公告 $5.7m Milestone Monetization Agreement with AOP SHIELD THERAPEUT资讯 07-03 15:25
69 0 公告 Results of 2024 Annual General Meeting SHIELD THERAPEUT资讯 06-21 00:33
64 0 公告 New Drug Application for Accrufer in South Korea SHIELD THERAPEUT资讯 05-28 15:20
71 0 公告 Audited results for the year ended 31 Dec 2023 SHIELD THERAPEUT资讯 05-10 23:37
62 0 公告 Business Update for Q1 2024 SHIELD THERAPEUT资讯 04-30 15:07
67 0 公告 Notice of Results SHIELD THERAPEUT资讯 04-16 15:22
90 0 公告 Unaudited Full Year Trading Update SHIELD THERAPEUT资讯 02-21 16:08
63 0 公告 Appointment of new Chief Financial Officer SHIELD THERAPEUT资讯 01-09 16:11
91 0 公告 Q3 2023 U.S. Commercial Highlights SHIELD THERAPEUT资讯 12-07 16:11
92 0 公告 PDMR Transaction Notification SHIELD THERAPEUT资讯 11-28 02:32
107 0 公告 Abstract to be presented at Healthcare Conference SHIELD THERAPEUT资讯 10-20 18:52
97 0 公告 Chief Financial Officer Transition SHIELD THERAPEUT资讯 10-12 15:08
86 0 公告 Result of REX Retail Offer SHIELD THERAPEUT资讯 10-03 23:07
92 0 公告 Completion of SWK Financing SHIELD THERAPEUT资讯 10-03 15:10
89 0 公告 Block listing Interim Return SHIELD THERAPEUT资讯 10-03 15:09
79 0 公告 Successful completion of US$6.1m Equity Fundraise SHIELD THERAPEUT资讯 09-28 20:57
91 0 公告 REX Retail Offer SHIELD THERAPEUT资讯 09-28 15:11
80 0 公告 $20m secured debt facility &proposed equity raise SHIELD THERAPEUT资讯 09-28 15:09
80 0 公告 Interim results update and business update SHIELD THERAPEUT资讯 09-28 15:09
81 0 公告 Notice of Results and Change in reporting currency SHIELD THERAPEUT资讯 09-06 15:04
105 0 公告 Holding(s) in Company SHIELD THERAPEUT资讯 07-24 22:35
90 0 公告 Business Update and U.S. Q2 2023 Highlights SHIELD THERAPEUT资讯 07-20 15:18
96 0 公告 Results of 2023 Annual General Meeting SHIELD THERAPEUT资讯 06-29 01:32
96 0 公告 Grant of share options to the CEO SHIELD THERAPEUT资讯 06-06 18:17
97 0 公告 Holding(s) in Company SHIELD THERAPEUT资讯 06-01 19:03
156 0 公告 Holding(s) in Company SHIELD THERAPEUT资讯 06-01 19:03
110 0 公告 Total Voting Rights SHIELD THERAPEUT资讯 05-31 15:09
108 0 公告 2022 Annual Report and 2023 AGM Notice SHIELD THERAPEUT资讯 05-19 15:08
104 0 公告 Form 8 (OPD) - Shield Therapeutics plc SHIELD THERAPEUT资讯 05-18 23:19
131 0 公告 Rule 2.9 Announcement and TVR Update SHIELD THERAPEUT资讯 05-10 00:23
115 0 公告 Business Update and Unaudited Results SHIELD THERAPEUT资讯 04-27 15:04
107 0 公告 Notice of Results SHIELD THERAPEUT资讯 04-12 15:07
149 0 公告 Appointment of Chief Commercial Officer SHIELD THERAPEUT资讯 04-05 15:04
149 0 公告 Block Listing 6 Monthly Return SHIELD THERAPEUT资讯 03-31 15:03
336 0 公告 Price Monitoring Extension SHIELD THERAPEUT资讯 03-16 02:17
195 0 公告 Total Voting Rights Update SHIELD THERAPEUT资讯 02-28 16:20
170 0 公告 Price Monitoring Extension SHIELD THERAPEUT资讯 02-17 20:13
170 0 公告 Second Price Monitoring Extn SHIELD THERAPEUT资讯 02-17 20:13
155 0 公告 Second Price Monitoring Extn SHIELD THERAPEUT资讯 02-10 01:52
140 0 公告 Price Monitoring Extension SHIELD THERAPEUT资讯 02-10 01:50
158 0 公告 Second Price Monitoring Extn SHIELD THERAPEUT资讯 02-09 18:12
163 0 公告 Price Monitoring Extension SHIELD THERAPEUT资讯 02-09 18:08
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
温馨提示: 1.根据《证券法》规定,禁止编造、传播虚假信息或者误导性信息,扰乱证券市场;2.用户在本社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500